Dedicated to improving access to comprehensive genomic profiling for advanced cancer patients.https://accesstocgp.com/en-ushttps://accesstocgp.com/news/acgp-submits-comments-to-cms-on-crush-initiative/https://accesstocgp.com/news/acgp-submits-comments-to-cms-on-crush-initiative/ACGP shares CMS's commitment to eliminating fraud, waste, and abuse, and believes this goal can be achieved without undermining the progress precision oncology has made possible.Mon, 30 Mar 2026 00:00:00 GMThttps://accesstocgp.com/news/the-access-to-comprehensive-genomic-profiling-coalition-announces-the-appointment-of-dr-john-fox-as-chair/https://accesstocgp.com/news/the-access-to-comprehensive-genomic-profiling-coalition-announces-the-appointment-of-dr-john-fox-as-chair/John Fox, MD, MHA, Senior Medical Director of the Americas, Market Access for Illumina, has been appointed Chair of ACGP.Thu, 31 Aug 2023 00:00:00 GMThttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-welcomes-merck-as-a-member-301705456.htmlhttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-welcomes-merck-as-a-member-301705456.htmlACGP announced the addition of Merck to its coalition of companies advocating for coverage of comprehensive genomic profiling for patients living with advanced cancer by U.S. health insurers.Mon, 19 Dec 2022 00:00:00 GMThttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-welcomes-blueprint-medicines-as-a-member-301526537.htmlhttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-welcomes-blueprint-medicines-as-a-member-301526537.htmlACGP announced the addition of Blueprint Medicines to its coalition of companies advocating for coverage of comprehensive genomic profiling for patients living with advanced cancer by U.S. health insurers.Fri, 15 Apr 2022 00:00:00 GMThttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-welcomes-strata-oncology-as-a-member-301328774.htmlhttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-welcomes-strata-oncology-as-a-member-301328774.htmlACGP announced the addition of Strata Oncology, a precision oncology company advancing molecular indications for cancer therapies.Mon, 12 Jul 2021 00:00:00 GMThttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-welcomes-two-new-members----pgdx-and-sema4-301317846.htmlhttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-welcomes-two-new-members----pgdx-and-sema4-301317846.htmlACGP announced the addition of Personal Genome Diagnostics (PGDx), a leader in cancer genomics, and Sema4, a patient-centered health intelligence company.Wed, 23 Jun 2021 00:00:00 GMThttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-adds-new-member-301294917.htmlhttps://www.prnewswire.com/news-releases/the-access-to-comprehensive-genomic-profiling-coalition-adds-new-member-301294917.htmlACGP announced the addition of Mayo Clinic Laboratories to its coalition of diagnostics companies and laboratory service providers.Thu, 20 May 2021 00:00:00 GMThttps://accesstocgp.com/news/precision-medicine-leadership-summits-virtual-series/https://accesstocgp.com/news/precision-medicine-leadership-summits-virtual-series/ACGP members joined the panel "Comprehensive Genomic Profiling: A New Standard of Care in Oncology" at the Precision Medicine Leadership Summit's Virtual Series.Tue, 27 Apr 2021 00:00:00 GMThttps://www.prnewswire.com/news-releases/astrazeneca-loxo-oncology-at-lilly-and-invitae-corporation-join-the-access-to-comprehensive-genomic-profiling-coalition-301270830.htmlhttps://www.prnewswire.com/news-releases/astrazeneca-loxo-oncology-at-lilly-and-invitae-corporation-join-the-access-to-comprehensive-genomic-profiling-coalition-301270830.htmlACGP announced the addition of AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation to its coalition of companies advocating for appropriate coverage of comprehensive genomic profiling.Mon, 19 Apr 2021 00:00:00 GMThttps://www.prnewswire.com/news-releases/neogenomics-and-tempus-join-the-access-to-comprehensive-genomic-profiling-coalition-301218197.htmlhttps://www.prnewswire.com/news-releases/neogenomics-and-tempus-join-the-access-to-comprehensive-genomic-profiling-coalition-301218197.htmlACGP announced the addition of NeoGenomics, Inc. and Tempus to its coalition of diagnostics companies and laboratory service providers advocating for broad U.S. health insurance coverage of comprehensive genomic profiling.Tue, 02 Feb 2021 00:00:00 GMThttps://www.prnewswire.com/news-releases/leading-diagnostics-companies-join-forces-to-establish-the-access-to-comprehensive-genomic-profiling-coalition-acgp-301173029.htmlhttps://www.prnewswire.com/news-releases/leading-diagnostics-companies-join-forces-to-establish-the-access-to-comprehensive-genomic-profiling-coalition-acgp-301173029.htmlSeven leading diagnostics companies and laboratory service providers formed ACGP, a consortium aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S.Tue, 10 Nov 2020 00:00:00 GMT